4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Oncolytics Biotech Inc. (ONCY) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 29 employees. Its market capitalization is roughly $102 million. In the fiscal year ended 2025-12-31, ONCY reported $0M in revenue and ($29M) in net income.
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($29M) | ($26M) | ($26M) | ($20M) | — |
| Net Income | ($29M) | ($23M) | ($21M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($10M) | ($10M) | ($4M) | ($5M) | — |
| Net Income | ($9M) | ($9M) | ($10M) | ($4M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $13M | $29M | $28M | — |
| Total Liabilities | $11M | $10M | $8M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ONCY viewer.
About TickerBase · Data methodology & sources